NCT02540031View on ClinicalTrials.gov

The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

June 30, 2018

Conditions
Bowel Preparation Quality
Interventions
DRUG

"Additional oral preparation (3L of PEG+Asc, Coolprep®)"

"The interventional or experimental arm will receive 1l of additional PEG+Asc, Coolprep® on the day of colonoscopy~\* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g"

DRUG

"Standard oral preparation (2L of PEG+Asc, Coolprep®)"

"The control arm will receive currently used oral preparation (2l of PEG+Asc, Coolprep®) for colonoscopy~\* Compositions/1L : Sodium Chloride 2.691g Potassium Chloride 1.015g Anhydrous sodium sulfate 7.5g PEG 3350 100g ascorbic acid 4.7g sodium ascorbate 5.9g"

Trial Locations (1)

700-712

Keimyung University Dongsan Medical Center, Daegu

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER

NCT02540031 - The Impact of Additional Oral Preparation on the Quality of Bowel Preparation for Colonoscopy | Biotech Hunter | Biotech Hunter